Matthew Snakenberg

Matthew Snakenberg has extensive experience in business development, licensing, and mergers and acquisitions. Matthew worked at Alcon as Vice President, Global Head - Business Development & Licensing / M&A from 2015 to present. Prior to that, they worked at Novartis as Sr. Director, Head of Business Development, Licensing and M&A from 2010 to 2015. Matthew also gained experience at Kimberly-Clark, where they held various roles including Strategy and Business Development, Mergers and Acquisitions from 2004 to 2010, Brand Manager - Scott Tissue from 2005 to 2006, and Senior Strategic Analyst - Corporate Strategy, Finance, M&A from 2003 to 2005.

Matthew Snakenberg obtained a Bachelor's degree in Finance and Accounting from the University of Iowa from 1993 to 1997. Matthew later completed a certification in Executive Private Equity and Venture Capital Program at Harvard Business School. In 2011, they attended The Wharton School for an Executive Negotiation Program. Additionally, Matthew attended Northwestern University's Kellogg School of Management for an Executive Merger and Acquisition Program, although specific dates for this program are not provided.